SPNE

SeaSpine Announces 100th Placement of 7D FLASH™ Navigation System

Retrieved on: 
Tuesday, December 27, 2022
FLASH, Navigation, Anatomy, Inova Health System, Inova Fairfax Hospital, SPNE, Radiation, Growth, Patient, Radiation exposure, Navigation system, National Center for Spinal Disorders, Medical device

CARLSBAD, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the placement of its 100th 7D FLASH™ Navigation System globally.

Key Points: 
  • CARLSBAD, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the placement of its 100th 7D FLASH™ Navigation System globally.
  • The 7D FLASH™ Navigation System uses visible light to create a three-dimensional image for surgical navigation in just seconds, which is expected to result in shorter and more efficient spinal procedures with less radiation exposure.
  • It is the only marketed image-guidance system that utilizes novel and proprietary camera-based technology, coupled with machine-vision algorithms, to eliminate the long-standing frustrations with legacy surgical navigation platforms.
  • “Their unique segmental referencing method and FLASH navigation system will protect patients and providers from the cumulative effects of radiation while allowing for more accurate placement of spinal fixation.

SEASPINE HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of SeaSpine Holdings Corporation - SPNE

Retrieved on: 
Wednesday, November 30, 2022
Legal, Professional Services, SPNE, KSF, Sale

and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of SeaSpine Holdings Corporation (NasdaqGS: SPNE) with Orthofix Medical Inc. (NasdaqGS: OFIX).

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of SeaSpine Holdings Corporation (NasdaqGS: SPNE) with Orthofix Medical Inc. (NasdaqGS: OFIX).
  • Under the terms of the proposed transaction, shareholders of SeaSpine will receive only 0.4163 shares of Orthofix for each share of SeaSpine that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing

Retrieved on: 
Friday, November 18, 2022
Software, MIS, Growth, CFO, SPNE, Communication, Merck & Co., Nature, Navigation, Form 10-K, The College of New Jersey, Risk, R, Value chain, Merck, College, Patient, Spine, Integra, National Center for Spinal Disorders, Prospectus, Spinal fusion, Annual general meeting, Neurosurgery, Senior, Security (finance), JOINT, PricewaterhouseCoopers, Sale, Surgeon, 8-K, Research, Form, Management

Bostjancic currently serves as the CFO and Chief Operating Officer of SeaSpine, roles he has held since 2015 and 2022 respectively.

Key Points: 
  • Bostjancic currently serves as the CFO and Chief Operating Officer of SeaSpine, roles he has held since 2015 and 2022 respectively.
  • John has been a key leader of SeaSpine dating back to the successful spin-out of the organization in 2015.
  • As announced on October 11, 2022, Orthofix and SeaSpine agreed to combine in an all-stock merger of equals.
  • The transaction is expected to close in the first quarter of 2023 subject to Orthofix and SeaSpine shareholder approvals and other customary closing conditions.

INVESTOR ALERT: The M&A Class Action Firm Continues Investigating the Merger –SPNE, LMST, JVA, SMBC

Retrieved on: 
Tuesday, November 15, 2022
SPNE, United States Court of Appeals for the Ninth Circuit, Telephone, Monteverde, JVA, Mergers and acquisitions, Lawyer, LMST, Empire, Greenhouse effect (United States Supreme Court), Security (finance), Sale, Martindale-Hubbell, Rising Star, Investment, Supreme court, Acquisition, SMBC, Citizenship

Coffee Holding Co., Inc. ( JVA ), relating to its proposed merger with Delta Corp Holdings Ltd. Click here for more information: https://www.monteverdelaw.com/case/coffee-holding-co-inc .

Key Points: 
  • Coffee Holding Co., Inc. ( JVA ), relating to its proposed merger with Delta Corp Holdings Ltd. Click here for more information: https://www.monteverdelaw.com/case/coffee-holding-co-inc .
  • We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing.
  • We were listed in the Top 50 in the 2018-2021 ISS Securities Class Action Services Report.
  • Also, we have recovered or secured over a dozen cash common funds for shareholders in mergers & acquisitions class action cases.

Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing

Retrieved on: 
Friday, November 18, 2022
General Health, Surgery, Medical Devices, Health, Health Technology, The College of New Jersey, Sale, Communication, R, Integra, Surgeon, Software, 8-K, Senior, Merck, Spine, Spinal fusion, Annual general meeting, SPNE, CFO, Form, Patient, Prospectus, Multimedia, Neurosurgery, Value chain, Research, Form 10-K, Security (finance), Nature, National Center for Spinal Disorders, PricewaterhouseCoopers, JOINT, MIS, Growth, College, Merck & Co., Risk, Navigation, Management

John has been a key leader of SeaSpine dating back to the successful spin-out of the organization in 2015.

Key Points: 
  • John has been a key leader of SeaSpine dating back to the successful spin-out of the organization in 2015.
  • Doug Rice, current CFO of Orthofix, will provide post-closing assistance with the integration activities during a transition period.
  • As announced on October 11, 2022, Orthofix and SeaSpine agreed to combine in an all-stock merger of equals.
  • The transaction is expected to close in the first quarter of 2023 subject to Orthofix and SeaSpine shareholder approvals and other customary closing conditions.

SeaSpine to Present at the Stifel 2022 Healthcare Conference

Retrieved on: 
Wednesday, November 2, 2022
Surgeon, Software, SPNE, Spinal fusion, Conference, National Center for Spinal Disorders, GLOBE, Neurosurgery, Navigation, NASDAQ, Company, MIS, Patient, Medical device, Dentistry

CARLSBAD, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation(NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the upcoming Stifel 2022 Healthcare Conference.

Key Points: 
  • CARLSBAD, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation(NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the upcoming Stifel 2022 Healthcare Conference.
  • Members of management are scheduled to present on Wednesday, November 16, 2022 at 12:35 p.m. Pacific time / 3:35 p.m. Eastern time.
  • SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders.
  • SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.

SeaSpine Announces 45% Revenue Growth and Record Revenue for Third Quarter 2022

Retrieved on: 
Tuesday, November 1, 2022
Security (finance), Marketing, Surgeon, Software, Growth, Pressure, International, Inc., EBITDA, SPNE, Spinal fusion, U.S. Securities and Exchange Commission, News, National Center for Spinal Disorders, GLOBE, Risk, COVID-19, Neurosurgery, Research, Navigation, NASDAQ, Company, MIS, Patient, Severe acute respiratory syndrome coronavirus 2, GAAP, Attention, Pharmaceutical industry, Video game, Bank

U.S. revenue growth was strong across all portfolios and was led by 30% growth in the spinal implants and enabling technologies portfolio.

Key Points: 
  • U.S. revenue growth was strong across all portfolios and was led by 30% growth in the spinal implants and enabling technologies portfolio.
  • Gross margin for the third quarter of 2022 was 60.3%, compared to 60.6% for the third quarter of 2021.
  • Adjusted gross margin (as described below) for the third quarter of 2022 was 61.8%, compared to 64.3% for the third quarter of 2021.
  • This revenue range reflects growth of 16% to 19% for the fourth quarter of 2022, after excluding European spinal implants revenue generated in the fourth quarter of 2021.

SeaSpine Announces Full Commercial Launch of the Mariner MIS Wayfinder System

Retrieved on: 
Monday, October 31, 2022
Surgeon, Software, MI, SPNE, Marketing, FLASH, Spinal fusion, News, National Center for Spinal Disorders, GLOBE, Neurosurgery, Exchange, Henry Ford Health System, Navigation, NASDAQ, Company, Sailor, MIS, U.S. Securities and Exchange Commission, Patient, Pharmaceutical industry

CARLSBAD, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation(NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Mariner MIS Wayfinder System.

Key Points: 
  • CARLSBAD, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation(NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Mariner MIS Wayfinder System.
  • Mariner MIS Wayfinder is a novel, one step, k-wireless screw delivery system for pedicle screw fixation.
  • Mariner MIS Wayfinder is fully integrated with the 7D FLASH Navigation Systems recently launched FLASH Percutaneous module.
  • Mariner MIS Wayfinder has been a powerful addition to the Mariner platform, stated Mike Hall, Vice President, Marketing.

SeaSpine to Report Third Quarter 2022 Financial Results on November 1, 2022

Retrieved on: 
Monday, October 24, 2022
Software, GLOBE, NASDAQ, Patient, National Center for Spinal Disorders, Spinal fusion, Surgeon, Investor, SPNE, Neurosurgery, MIS, Navigation, Medical device

CARLSBAD, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Tuesday, November 1, 2022.

Key Points: 
  • CARLSBAD, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Tuesday, November 1, 2022.
  • Members of the Companys management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET.
  • To listen to the live webcast and a replay, please visit the Investors section of the SeaSpine website at: https://www.seaspine.com/ .
  • SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.

SeaSpine Announces Full Commercial Launch of the 7D FLASH™ Navigation System Percutaneous Spine Module for Minimally Invasive Surgery

Retrieved on: 
Tuesday, October 18, 2022
Adoption, News, U.S. Securities and Exchange Commission, Efficiency, SPNE, Enabling technology, Navigation, Algorithm, NASDAQ, Patient, Hospital, Security (finance), Spine, Software, Spinal fusion, MIS, Radiation, GLOBE, National Center for Spinal Disorders, Surgeon, Neurosurgery, Medical device, Dentistry

CARLSBAD, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the 7D FLASH Navigation System Percutaneous Spine Module.

Key Points: 
  • CARLSBAD, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the 7D FLASH Navigation System Percutaneous Spine Module.
  • The release of the Percutaneous Module represents a new application and increased functionality for its 7D FLASH Navigation System, which now allows SeaSpine to further penetrate the minimally invasive spine surgery market, which SeaSpine estimates at approximately $4 billion worldwide.
  • The addition of the Percutaneous Module to the FLASH Navigation System has brought versatility to my OR, stated Dr. Douglas Orndorff of Spine Colorado.
  • Our Percutaneous Module has expanded the clinical functionality of the FLASH Navigation System by providing surgeons with a fully integrated procedural solution for minimally invasive surgery, said Dr.